K

L

Lauxera Capital Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Equity

O
OrganOx

Organ medical technology • Organ failure

OrganOx develops medical technologies to enhance organ transplant outcomes, particularly through its metra® platform for liver and kidney transplants.

Equity
$142M
02/24/2025
Article
C
Caresyntax

AI-enabled • Surgical software

Symbiotic Capital logo
Relyens Group logo
ProAssurance logo
Plug & Play logo

Caresyntax develops AI-enabled surgical software that enhances surgical outcomes by integrating and analyzing comprehensive data to support real-time and post-surgical decision-making.

Hybrid C
$180M
08/16/2024
Article
B
BioLamina

Biotech • Recombinant Proteins

Northislet logo
Lauxera Capital Partners logo
Bure Equity logo

BioLamina is a Swedish biotech company that specializes in developing and producing recombinant human laminins, key proteins used for growing and manipulating stem cells and primary cells, to support the production of stem cell-derived therapeutics and advanced cell-based disease models.

Equity
$18.2M
09/12/2023
Article